Abstract
Early Onset of Action and Sustained Efficacy of MRI Outcomes During Cladribine Tablets Treatment in Highly Active Relapsing Multiple Sclerosis: Results of the 2-year MAGNIFY-MS Study (P6-3.018)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have